1 |
Roux FA, Saï P, Deschamps JY. Xenotransfusions, past and present[J]. Xenotransplantation, 2007,14(3):208-216.
|
2 |
Cooper DK, Gollackner B, Sachs DH. Will the pig solve the transplantation backlog?[J]. Annu Rev Med, 2002,53:133-147.
|
3 |
Lunney JK, Van Goor A, Walker KE, et al. Importance of the pig as a human biomedical model[J]. Sci Transl Med, 2021,13(621):eabd5758.
|
4 |
Cooper DK. A brief history of cross-species organ transplantation[J]. Proc (Bayl Univ Med Cent), 2012,25(1):49-57.
|
5 |
Chiche L, Adam R, Caillat-Zucman S, et al. Xenotransplantation: baboons as potential liver donors? Scientific and ethical issues[J]. Transplantation, 1993,55(6):1418-1421.
|
6 |
Montgomery RA, Mehta SA, Parent B, et al. Next steps for the xenotransplantation of pig organs into humans[J]. Nat Med, 2022,28(8):1533-1536.
|
7 |
Yamamoto T, Iwase H, King TW, et al. Skin xenotransplantation: historical review and clinical potential[J]. Burns, 2018,44(7):1738-1749.
|
8 |
Reemtsma K, McCracken BH, Schlegel JU, et al. Renal heterotransplantation in man[J]. Ann Surg, 1964,160(3):384-410.
|
9 |
Hardy JD, Kurrus FD, Chavez CM, et al. Heart transplantation in man. Developmental studies and report of a case [J]. JAMA, 1964,188:1132-1140.
|
10 |
Cooper DKC, Ekser B, Tector AJ. A brief history of clinical xenotransplantation[J]. Int J Surg, 2015,23(Pt B):205-210.
|
11 |
Cooper DK, Ekser B, Ramsoondar J, et al. The role of genetically engineered pigs in xenotransplantation research[J]. J Pathol, 2016,238(2):288-299.
|
12 |
Lu T, Yang B, Wang R, et al. Xenotransplantation: current status in preclinical research[J]. Front Immunol, 2019,10:3060.
|
13 |
Ryczek N, Hryhorowicz M, Zeyland J, et al. CRISPR/Cas technology in pig-to-human xenotransplantation research[J]. Int J Mol Sci, 2021,22(6):3196.
|
14 |
Lexer G, Cooper DK, Rose AG, et al. Hyperacute rejection in a discordant (pig to baboon) cardiac xenograft model[J]. J Heart Transplant, 1986,5(6):411-418.
|
15 |
Phelps CJ, Koike C, Vaught TD, et al. Production of alpha 1,3-galactosyltransferase-deficient pigs[J]. Science, 2003,299(5605):411-414.
|
16 |
Mohiuddin MM, Singh AK, Corcoran PC, et al. Chimeric 2C10R4 anti-CD40 antibody therapy is critical for long-term survival of GTKO.hCD46.hTBM pig-to-primate cardiac xenograft[J]. Nat Commun, 2016,7:11138.
|
17 |
Brenner P, Mihalj M. Update and breakthrough in cardiac xenotransplantation[J]. Curr Opin Organ Transplant, 2020,25(3):261-267.
|
18 |
Goerlich CE, Griffith B, Singh AK, et al. Blood cardioplegia induction, perfusion storage and graft dysfunction in cardiac xenotransplantation[J]. Front immunol, 2021,12:667093.
|
19 |
DiChiacchio L, Singh AK, Lewis B, et al. Early experience with preclinical perioperative cardiac xenograft dysfunction in a single program[J]. Ann Thorac Surg, 2020,109(5):1357-1361.
|
20 |
Roberts WC, Kondapalli N, Guileyardo JM. Morphologic findings in donor (transplanted) hearts at necropsy early and late after orthotopic heart transplantation[J]. Am J Cardiol, 2018,121(2):217-240.
|
21 |
Hinrichs A, Kessler B, Kurome M, et al. Growth hormone receptor-deficient pigs resemble the pathophysiology of human Laron syndrome and reveal altered activation of signaling cascades in the liver[J]. Mol Metab, 2018,11:113-128.
|
22 |
Ekser B, Lin CC, Long C, et al. Potential factors influencing the development of thrombocytopenia and consumptive coagulopathy after genetically modified pig liver xenotransplantation[J]. Transpl Int, 2012,25(8):882-896.
|
23 |
Ekser B, Echeverri GJ, Hassett AC, et al. Hepatic function after genetically engineered pig liver transplantation in baboons[J]. Transplantation, 2010,90(5):483-493.
|
24 |
Kim K, Schuetz C, Elias N, et al. Up to 9-day survival and control of thrombocytopenia following alpha1,3-galactosyl transferase knockout swine liver xenotransplantation in baboons[J]. Xenotransplantation, 2012,19(4):256-264.
|
25 |
Paris LL, Chihara RK, Reyes LM, et al. ASGR1 expressed by porcine enriched liver sinusoidal endothelial cells mediates human platelet phagocytosis in vitro[J]. Xenotransplantation, 2011,18(4):245-251.
|
26 |
Paris LL, Estrada JL, Li P, et al. Reduced human platelet uptake by pig livers deficient in the asialoglycoprotein receptor 1 protein[J]. Xenotransplantation, 2015,22(3):203-210.
|
27 |
Kim SC, Mathews DV, Breeden CP, et al. Long-term survival of pig-to-rhesus macaque renal xenografts is dependent on CD4 T cell depletion[J]. Am J Transplant, 2019,19(8):2174-2185.
|
28 |
Yu XH, Deng WY, Jiang HT, et al. Kidney xenotransplantation: recent progress in preclinical research[J]. Clin Chim Acta, 2021,514:15-23.
|
29 |
Wang L, Cooper D, Burdorf L, et al. Overcoming coagulation dysregulation in pig solid organ transplantation in nonhuman primates: recent progress[J]. Transplantation, 2018,102(7):1050-1058.
|
30 |
Dwyer KM, Mysore TB, Crikis S, et al. The transgenic expression of human CD39 on murine islets inhibits clotting of human blood[J]. Transplantation, 2006,82(3):428-432.
|
31 |
Niemann H, Petersen B. The production of multi-transgenic pigs: update and perspectives for xenotransplantation[J]. Transgenic Res, 2016,25(3):361-374.
|
32 |
Nguyen BN, Azimzadeh AM, Zhang T, et al. Life-supporting function of genetically modified swine lungs in baboons[J]. J Thorac Cardiovasc Surg, 2007,133(5):1354-1363.
|
33 |
Burdorf L, Laird CT, Harris DG, et al. Pig-to-baboon lung xenotransplantation: extended survival with targeted genetic modifications and pharmacologic treatments[J]. Am J Transplant, 2022,22(1):28-45.
|
34 |
Watanabe H, Sahara H, Nomura S, et al. GalT-KO pig lungs are highly susceptible to acute vascular rejection in baboons, which may be mitigated by transgenic expression of hCD47 on porcine blood vessels[J]. Xenotransplantation, 2018,25(5):e12391.
|
35 |
Matsumoto S, Tan P, Baker J, et al. Clinical porcine islet xenotransplantation under comprehensive regulation[J]. Transplant Proc, 2014,46(6):1992-1995.
|
36 |
Liu Z, Hu W, He T, et al. Pig-to-primate islet xenotransplantation: past, present, and future[J]. Cell Transplant, 2017,26(6):925-947.
|
37 |
Galili U. The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy[J]. Immunol Cell Biol, 2005,83(6):674-686.
|
38 |
Ladowski JM, Houp J, Hauptfeld-Dolejsek V, et al. Aspects of histocompatibility testing in xenotransplantation[J]. Transpl Immunol, 2021,67:101409.
|
39 |
Byrne G, Ahmad-Villiers S, Du Z, et al. B4GALNT2 and xenotransplantation: a newly appreciated xenogeneic antigen[J]. Xenotransplantation, 2018,25(5):e12394.
|
40 |
Estrada JL, Martens G, Li P, et al. Evaluation of human and non-human primate antibody binding to pig cells lacking GGTA1/CMAH/β4GalNT2 genes[J]. Xenotransplantation, 2015,22(3):194-202.
|
41 |
Ierino FL, Sandrin MS. Spectrum of the early xenograft response: from hyperacute rejection to delayed xenograft injury[J]. Crit Rev Immunol, 2007,27(2):153-166.
|
42 |
Zhou Q, Li T, Wang K, et al. Current status of xenotransplantation research and the strategies for preventing xenograft rejection[J]. Front Immunol, 2022,13:928173.
|
43 |
Niemann H, Petersen B. The production of multi-transgenic pigs: update and perspectives for xenotransplantation[J]. Transgenic Res, 2016,25(3):361-374.
|
44 |
Petersen B, Ramackers W, Lucas-Hahn A, et al. Transgenic expression of human heme oxygenase-1 in pigs confers resistance against xenograft rejection during ex vivo perfusion of porcine kidneys[J]. Xenotransplantation, 2011,18(6):355-68.
|
45 |
Sullivan JA, Oettinger HF, Sachs DH, et al. Analysis of polymorphism in porcine MHC class I genes: alterations in signals recognized by human cytotoxic lymphocytes[J]. J Immunol, 1997,159(5):2318-2326.
|
46 |
Resch T, Fabritius C, Ebner S, et al. The role of natural killer cells in humoral rejection[J]. Transplantation, 2015,99(7):1335-1340.
|
47 |
Vadori M, Cozzi E. The immunological barriers to xenotransplantation[J]. Tissue Antigens, 2015,86(4):239-253.
|
48 |
Iwase H, Ezzelarab MB, Ekser B, et al. The role of platelets in coagulation dysfunction in xenotransplantation, and therapeutic options[J]. Xenotransplantation, 2014,21(3):201-220.
|
49 |
Zelaya H, Rothmeier AS, Ruf W. Tissue factor at the crossroad of coagulation and cell signaling[J]. J Thromb Haemost, 2018,16(10):1941-1952.
|
50 |
Kim H, Hawthorne WJ, Kang HJ, et al. Human thrombomodulin regulates complement activation as well as the coagulation cascade in xeno-immune response[J]. Xenotransplantation, 2015,22(4):260-272.
|
51 |
Ekser B, Long C, Echeverri GJ, et al. Impact of thrombocytopenia on survival of baboons with genetically modified pig liver transplants: clinical relevance[J]. Am J Transplant, 2010,10(2):273-285.
|
52 |
Schulte Am Esch J 2nd, Robson SC, Knoefel WT, et al. O-linked glycosylation and functional incompatibility of porcine von Willebrand factor for human platelet GPIb receptors[J]. Xenotransplantation, 2005,12(1):30-37.
|
53 |
Blasier D, Mayba I, Ferguson C, et al. Metastatic osteosarcoma and multiple lung resection. A case report[J]. J Bone Joint Surg Br, 1986,68(5):748-750.
|
54 |
Paris LL, Chihara RK, Sidner RA, et al. Differences in human and porcine platelet oligosaccharides may influence phagocytosis by liver sinusoidal cells in vitro[J]. Xenotransplantation, 2012,19(1):31-39.
|
55 |
Fishman JA. Infectious disease risks in xenotransplantation[J]. Am J Transplant, 2018,18(8):1857-1864.
|
56 |
Semaan M, Rotem A, Barkai U, et al. Screening pigs for xenotransplantation: prevalence and expression of porcine endogenous retroviruses in Göttingen minipigs[J]. Xenotransplantation, 2013,20(3):148-156.
|
57 |
Denner J, Schuurman HJ. High prevalence of recombinant porcine endogenous retroviruses (PERV-A/Cs) in minipigs: a review on origin and presence[J]. Viruses, 2021,13(9):1869.
|
58 |
Denner J. Why was PERV not transmitted during preclinical and clinical xenotransplantation trials and after inoculation of animals?[J]. Retrovirology, 2018,15(1):28.
|
59 |
Melo H, Brandao C, Rego G, et al. Ethical and legal issues in xenotransplantation[J]. Bioethics, 2001,15(5-6):427-442.
|
60 |
Entwistle JW, Sade RM, Drake DH. Clinical xenotransplantation seems close: ethical issues persist[J]. Artif Organs, 2022,46(6):987-994.
|
61 |
Locke LG. The promise of CRISPR for human germline editing and the perils of " playing God" [J]. CRISPR J, 2020,3(1):27-31.
|
62 |
Raposo VL. The first Chinese edited babies: a leap of faith in science[J]. JBRA Assist Reprod, 2019,23(3):197-199.
|
63 |
Fishman JA. Prevention of infection in xenotransplantation: designated pathogen-free swine in the safety equation[J]. Xenotransplantation, 2020,27(3):e12595.
|